The Cannabis Growth Fund is one of the first open-end mutual funds to invest primarily in companies related to the cannabis industry.
The Fund plans to invest primarily in exchange listed equity securities of companies in the cannabis industry. These companies are located around the globe and engaged exclusively in legal activities under national and local laws, including U.S. federal and state law, as applicable.1,2 Many companies that the Fund seeks to hold legally participate in activities including agriculture technology, biotechnology, cultivation and retail, products and extracts, industry hemp, and ancillary products and services that complement the cannabis industry. Diversified across various subsectors to provide broad-based exposure, the Fund helps investors capitalize on the fast-growing, innovative cannabis industry.
Why Professional Management?
Today the cannabis industry is growing quickly, with a universe of over 75 small-, mid- and large-cap companies that participate in medicinal or recreational use of cannabis. As this new industry changes and expands, we believe active management has advantages over purchasing individual companies or a passive ETF. In our opinion, knowledgeable and dedicated professionals help investors mitigate inherent volatility and identify favorable growth opportunities, such as initial public offerings. The Fund also has the flexibility to use options in an attempt to enhance the Fund’s return and reduce volatility.
Asset Allocation and the Cannabis Growth Fund
The Fund is a specialty and actively managed portfolio focused on investing in the cannabis industry, providing potentially small-cap, aggressive growth exposure. When including the Fund in an overall portfolio, investors should consider their long-term objectives and goals and place the Fund appropriately within an equity portfolio.3
Why Invest in the Cannabis Industry
More than 22 countries covering a population of nearly 1 billion have laws that cover the legal use of medical cannabis.1 With growing legalization, the global cannabis market is anticipated to grow over $30 billion by 2022.2
Cannabis and its cannabinoids have been found helpful in treating chronic pain, glaucoma, epileptic seizures and anxiety.
Cannabis has the potential to be used in an array of consumer products, such as beverages, energy drinks, coffee, alcohol, and other edible products.
The fibers and stalks of the plant are used in clothing, construction, body oil and lotions, plastic, and construction materials.
Robust M&A Activity
Significant consolidation and collaboration signal growth potential. In 2018, there were over 300 M&A transactions in the global cannabis industry
1 The Future of Legal Cannabis: Key Developments in the Emerging Global Industry. Frontier Financial Group, Inc., February 15, 2018.
2“Worldwide Legal Cannabis Spending Hits $12.2 Billion in 2018, projected to Grow 38% to $16.9 Billion in 2019,” BDS Analytics, January 15, 2019.
Statements, estimates and forecasts are subject to significant legal, business, economic, and competitive uncertainties. There can be no assurance that such estimates and/or forecasts will be realized, and these are not indicative of future investment performance. Historical data is not indicative of future performance
2 Pronouncements from the current Administration suggest the Department of Justice may take action against states to prevent them from implementing laws that authorize medical marijuana use, possession, distribution, and cultivation. This action may have a material effect on investment in companies involved in the cannabis industry.
3 Fund investments will be concentrated in an industry or group of industries, and the value of Fund shares may rise and fall more than more diversified funds.
CANNX NAV: $5.98 | Change: $0.05
CANIX NAV: $5.95 | Change: $0.05